HEADER RECEPTOR 15-AUG-00 1E6F TITLE HUMAN MIR-RECEPTOR, REPEAT 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650; COMPND 5 SYNONYM: MANNOSE-6-PHOSPHATE RECEPTOR, INSULIN-LIKE GROWTH-FACTOR II COMPND 6 RECEPTOR, CI MAN-6-P RECEPTOR, CI-MPR, 300 KDA MANNOSE 6-PHOSPHATE COMPND 7 RECEPTOR, MPR 300; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: BHK-21; SOURCE 6 ORGAN: KIDNEY; SOURCE 7 CELL: FIBROBLAST; SOURCE 8 CELLULAR_LOCATION: LYSOSOME; SOURCE 9 EXPRESSION_SYSTEM: CRICETINAE GEN. SP.; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 36483 KEYWDS RECEPTOR, MIR-RECEPTOR, IGF-II RECEPTOR, TRANSPORT, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.VON BUELOW,K.R.RAJASHANKAR,M.DAUTER,Z.DAUTER,S.GRIMME,B.SCHMIDT, AUTHOR 2 K.VON FIGURA,I.USON REVDAT 7 13-NOV-24 1E6F 1 REMARK REVDAT 6 24-JUL-19 1E6F 1 REMARK REVDAT 5 22-MAY-19 1E6F 1 REMARK REVDAT 4 30-JAN-19 1E6F 1 REMARK REVDAT 3 24-FEB-09 1E6F 1 VERSN REVDAT 2 15-JUN-05 1E6F 1 HEADER COMPND AUTHOR JRNL REVDAT 1 09-AUG-01 1E6F 0 JRNL AUTH I.USON,B.SCHMIDT,R.VON BUELOW,S.GRIMME,K.VON FIGURA, JRNL AUTH 2 M.DAUTER,K.R.RAJASHANKAR,Z.DAUTER,G.M.SHELDRICK JRNL TITL LOCATING THE ANOMALOUS SCATTERER SUBSTRUCTURES IN HALIDE AND JRNL TITL 2 SULFUR PHASING JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 59 57 2003 JRNL REFN ISSN 0907-4449 JRNL PMID 12499540 JRNL DOI 10.1107/S090744490201884X REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.222 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.221 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1431 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29383 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.218 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.216 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1378 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 28059 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2050.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 22 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8499 REMARK 3 NUMBER OF RESTRAINTS : 10697 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.017 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.039 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.046 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.008 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.048 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINED OCCUPANCY FOR ALTERNATIVE REMARK 3 DISORDERED SITES REMARK 4 REMARK 4 1E6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-AUG-00. REMARK 100 THE DEPOSITION ID IS D_1290005256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9057 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : BENT CRYSTALS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29383 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.753 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 15.00 REMARK 200 R MERGE (I) : 0.02500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 40.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.14700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 9.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: SHELXD, SHARP, DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRECIPITANT: 0.2 M AMMONIUM ACETATE, REMARK 280 0.1 M CACODYLATE PH 5 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML IN REMARK 280 10 MM TRIS-HCL PH7.5, 150 MM N VAPOUR DIFFUSION, HANGING DROPS,1: REMARK 280 1 RATIO., PH 5.70, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 TRANSPORT OF PHOSPHORYLATED LYSOSOMAL ENZYMES FROM REMARK 400 THE GOLGI COMPLEX AND THE CELL SURFACE TO LYSOSOMES. LYSOSOMAL REMARK 400 ENZYMES BEARING PHOSPHOMANNOSYL RESIDUES BIND SPECIFICALLY TO REMARK 400 MANNOSE-6-PHOSPHATE RECEPTORS IN THE GOLGI APPARATUS AND THE REMARK 400 RESULTING RECEPTOR-LIGAND COMPLEX IS TRANSPORTED TO AN ACIDIC REMARK 400 PRELYOSOMAL COMPARTMENT WHERE THE LOW PH MEDIATES THE DISSOCIATION REMARK 400 OF THE COMPLEX. THIS RECEPTOR ALSO BINDS INSULIN GROWTH FACTOR II. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1508 REMARK 465 LYS A 1509 REMARK 465 SER A 1510 REMARK 465 ASN A 1511 REMARK 465 GLU A 1512 REMARK 465 HIS A 1513 REMARK 465 GLU A 1617 REMARK 465 ALA A 1618 REMARK 465 GLY A 1619 REMARK 465 PRO A 1620 REMARK 465 THR A 1621 REMARK 465 GLN A 1648 REMARK 465 ALA A 1649 REMARK 465 THR A 1650 REMARK 465 MET B 1508 REMARK 465 LYS B 1509 REMARK 465 SER B 1510 REMARK 465 ASN B 1511 REMARK 465 GLU B 1512 REMARK 465 HIS B 1513 REMARK 465 ALA B 1618 REMARK 465 GLY B 1619 REMARK 465 PRO B 1620 REMARK 465 THR B 1621 REMARK 465 ALA B 1649 REMARK 465 THR B 1650 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A1514 CG OD1 OD2 REMARK 470 LYS A1601 CB CG CD CE NZ REMARK 470 SER A1602 CB OG REMARK 470 ARG A1615 NE CZ NH1 NH2 REMARK 470 ASN A1622 CG OD1 ND2 REMARK 470 ASP B1514 CG OD1 OD2 REMARK 470 GLU B1544 CG CD OE1 OE2 REMARK 470 SER B1602 OG REMARK 470 ARG B1615 NE CZ NH1 NH2 REMARK 470 GLU B1617 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1515 22.85 -144.82 REMARK 500 SER A1543 -159.83 56.18 REMARK 500 ARG A1571 19.29 58.71 REMARK 500 LYS A1601 -153.14 -65.60 REMARK 500 SER A1602 -79.10 -56.70 REMARK 500 SER A1602 13.09 -162.22 REMARK 500 ASP B1515 31.39 -142.31 REMARK 500 SER B1543 -152.12 58.03 REMARK 500 LYS B1545 16.94 -140.91 REMARK 500 ARG B1571 18.65 57.08 REMARK 500 REMARK 500 REMARK: NULL DBREF 1E6F A 1508 1650 UNP P11717 MPRI_HUMAN 1508 1650 DBREF 1E6F B 1508 1650 UNP P11717 MPRI_HUMAN 1508 1650 SEQRES 1 A 143 MET LYS SER ASN GLU HIS ASP ASP CYS GLN VAL THR ASN SEQRES 2 A 143 PRO SER THR GLY HIS LEU PHE ASP LEU SER SER LEU SER SEQRES 3 A 143 GLY ARG ALA GLY PHE THR ALA ALA TYR SER GLU LYS GLY SEQRES 4 A 143 LEU VAL TYR MET SER ILE CYS GLY GLU ASN GLU ASN CYS SEQRES 5 A 143 PRO PRO GLY VAL GLY ALA CYS PHE GLY GLN THR ARG ILE SEQRES 6 A 143 SER VAL GLY LYS ALA ASN LYS ARG LEU ARG TYR VAL ASP SEQRES 7 A 143 GLN VAL LEU GLN LEU VAL TYR LYS ASP GLY SER PRO CYS SEQRES 8 A 143 PRO SER LYS SER GLY LEU SER TYR LYS SER VAL ILE SER SEQRES 9 A 143 PHE VAL CYS ARG PRO GLU ALA GLY PRO THR ASN ARG PRO SEQRES 10 A 143 MET LEU ILE SER LEU ASP LYS GLN THR CYS THR LEU PHE SEQRES 11 A 143 PHE SER TRP HIS THR PRO LEU ALA CYS GLU GLN ALA THR SEQRES 1 B 143 MET LYS SER ASN GLU HIS ASP ASP CYS GLN VAL THR ASN SEQRES 2 B 143 PRO SER THR GLY HIS LEU PHE ASP LEU SER SER LEU SER SEQRES 3 B 143 GLY ARG ALA GLY PHE THR ALA ALA TYR SER GLU LYS GLY SEQRES 4 B 143 LEU VAL TYR MET SER ILE CYS GLY GLU ASN GLU ASN CYS SEQRES 5 B 143 PRO PRO GLY VAL GLY ALA CYS PHE GLY GLN THR ARG ILE SEQRES 6 B 143 SER VAL GLY LYS ALA ASN LYS ARG LEU ARG TYR VAL ASP SEQRES 7 B 143 GLN VAL LEU GLN LEU VAL TYR LYS ASP GLY SER PRO CYS SEQRES 8 B 143 PRO SER LYS SER GLY LEU SER TYR LYS SER VAL ILE SER SEQRES 9 B 143 PHE VAL CYS ARG PRO GLU ALA GLY PRO THR ASN ARG PRO SEQRES 10 B 143 MET LEU ILE SER LEU ASP LYS GLN THR CYS THR LEU PHE SEQRES 11 B 143 PHE SER TRP HIS THR PRO LEU ALA CYS GLU GLN ALA THR FORMUL 3 HOH *118(H2 O) HELIX 1 1 SER A 1530 LEU A 1532 5 3 HELIX 2 2 PRO A 1643 CYS A 1646 5 4 HELIX 3 3 SER B 1530 SER B 1533 5 4 HELIX 4 4 PRO B 1643 CYS B 1646 5 4 SHEET 1 A 2 GLN A1517 THR A1519 0 SHEET 2 A 2 LEU A1526 ASP A1528 -1 N PHE A1527 O VAL A1518 SHEET 1 B 3 PHE A1538 TYR A1542 0 SHEET 2 B 3 GLY A1546 MET A1550 -1 N MET A1550 O PHE A1538 SHEET 3 B 3 ALA A1565 PHE A1567 -1 N CYS A1566 O TYR A1549 SHEET 1 C 5 ARG A1582 VAL A1584 0 SHEET 2 C 5 VAL A1587 TYR A1592 -1 N GLN A1589 O ARG A1582 SHEET 3 C 5 LYS A1607 CYS A1614 -1 N PHE A1612 O LEU A1588 SHEET 4 C 5 THR A1635 THR A1642 1 N LEU A1636 O LYS A1607 SHEET 5 C 5 MET A1625 ASP A1630 -1 N ASP A1630 O THR A1635 SHEET 1 D 2 GLN B1517 THR B1519 0 SHEET 2 D 2 LEU B1526 ASP B1528 -1 N PHE B1527 O VAL B1518 SHEET 1 E 3 PHE B1538 TYR B1542 0 SHEET 2 E 3 GLY B1546 MET B1550 -1 N MET B1550 O PHE B1538 SHEET 3 E 3 ALA B1565 PHE B1567 -1 N CYS B1566 O TYR B1549 SHEET 1 F 5 ARG B1582 VAL B1584 0 SHEET 2 F 5 VAL B1587 TYR B1592 -1 N GLN B1589 O ARG B1582 SHEET 3 F 5 LYS B1607 CYS B1614 -1 N PHE B1612 O LEU B1588 SHEET 4 F 5 THR B1635 THR B1642 1 N LEU B1636 O LYS B1607 SHEET 5 F 5 MET B1625 ASP B1630 -1 N ASP B1630 O THR B1635 SSBOND 1 CYS A 1516 CYS A 1553 1555 1555 2.03 SSBOND 2 CYS A 1559 CYS A 1566 1555 1555 2.04 SSBOND 3 CYS A 1598 CYS A 1634 1555 1555 2.01 SSBOND 4 CYS A 1614 CYS A 1646 1555 1555 2.03 SSBOND 5 CYS B 1516 CYS B 1553 1555 1555 2.01 SSBOND 6 CYS B 1559 CYS B 1566 1555 1555 2.03 SSBOND 7 CYS B 1598 CYS B 1634 1555 1555 2.04 SSBOND 8 CYS B 1614 CYS B 1646 1555 1555 2.01 CRYST1 48.500 49.000 120.400 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020618 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020408 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008306 0.00000 MTRIX1 1 0.020570 -0.999790 -0.000140 7.67511 1 MTRIX2 1 -0.954560 -0.019600 -0.297360 20.07979 1 MTRIX3 1 0.297300 0.006250 -0.954760 21.65717 1